160 related articles for article (PubMed ID: 22133449)
1. Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians.
Torres MC; Beltrame MH; Santos IC; Picheth G; Petzl-Erler ML; Pedrosa FO; Steffens MB; de Souza EM
Int J Immunogenet; 2012 Apr; 39(2):155-60. PubMed ID: 22133449
[TBL] [Abstract][Full Text] [Related]
2. Association study of polymorphisms in the receptor for advanced glycation end-products (RAGE) gene with susceptibility and prognosis of heart failure.
Cohen CR; Diel VB; La Porta VL; Rohde LE; Biolo A; Clausell N; Dos Santos KG
Gene; 2012 Nov; 510(1):7-13. PubMed ID: 22964273
[TBL] [Abstract][Full Text] [Related]
3. The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians.
Santos IC; Daga DR; Frigeri HR; Réa RR; Almeida AC; Souza EM; Pedrosa FO; Fadel-Picheth CM; Picheth G
Genet Mol Res; 2010 Jun; 9(2):1130-5. PubMed ID: 20568058
[TBL] [Abstract][Full Text] [Related]
4. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes.
dos Santos KG; Canani LH; Gross JL; Tschiedel B; Pires Souto KE; Roisenberg I
Mol Genet Metab; 2005 Jun; 85(2):149-56. PubMed ID: 15896660
[TBL] [Abstract][Full Text] [Related]
5. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.
Laki J; Kiszel P; Vatay A; Blaskó B; Kovács M; Körner A; Madácsy L; Blatniczky L; Almássy Z; Szalai C; Rajczy K; Pozsonyi E; Karádi I; Fazakas A; Hosszúfalusi N; Pánczél P; Arason GJ; Wu YL; Zhou B; Yang Y; Yu CY; Füst G
Mol Immunol; 2007 Jan; 44(4):648-55. PubMed ID: 16504296
[TBL] [Abstract][Full Text] [Related]
6. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.
Carlo-Stella N; Bozzini S; De Silvestri A; Sbarsi I; Pizzochero C; Lorusso L; Martinetti M; Cuccia M
Int J Immunopathol Pharmacol; 2009; 22(3):745-54. PubMed ID: 19822091
[TBL] [Abstract][Full Text] [Related]
7. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
8. RAGE gene polymorphism and environmental factor in the risk of oral cancer.
Su S; Chien M; Lin C; Chen M; Yang S
J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438
[TBL] [Abstract][Full Text] [Related]
9. Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.
Aydoğan HY; Küçükhüseyin O; Tekeli A; Isbir T
Genet Test Mol Biomarkers; 2012 Feb; 16(2):134-7. PubMed ID: 21861709
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the receptor for advanced glycation end products as vasculopathy predictor in sickle cell disease.
Safwat NA; ELkhamisy MM; Abdel-Wahab SEA; Hamza MT; Boshnak NH; Kenny MA
Pediatr Res; 2021 Jan; 89(1):185-190. PubMed ID: 32544923
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
[TBL] [Abstract][Full Text] [Related]
12. Association of the receptor for advanced glycation end-products (RAGE) gene polymorphisms in Malaysian patients with chronic kidney disease.
Wong FN; Chua KH; Kuppusamy UR; Wong CM; Lim SK; Tan JA
PeerJ; 2016; 4():e1908. PubMed ID: 27114872
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM.
Kanková K; Záhejský J; Márová I; Muzík J; Kuhrová V; Blazková M; Znojil V; Beránek M; Vácha J
J Diabetes Complications; 2001; 15(4):185-92. PubMed ID: 11457670
[TBL] [Abstract][Full Text] [Related]
15. The interaction between obesity and RAGE polymorphisms on the risk of knee osteoarthritis in Chinese population.
Han Z; Liu Q; Sun C; Li Y
Cell Physiol Biochem; 2012; 30(4):898-904. PubMed ID: 22987041
[TBL] [Abstract][Full Text] [Related]
16. The -374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients.
Picheth G; Costantini CO; Pedrosa FO; Leme da Rocha Martinez T; Maltempi de Souza E
Clin Chem Lab Med; 2007; 45(10):1268-72. PubMed ID: 17924846
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
[TBL] [Abstract][Full Text] [Related]
19. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
[TBL] [Abstract][Full Text] [Related]
20. Functional promoter polymorphisms of the receptor for advanced glycation end products in children and adolescents with type 1 diabetes.
Gomes LC; Welter M; Gobor LC; Santos-Weiss ICR; França SN; Alberton D; Picheth G; Rego FG
Mol Cell Probes; 2015 Dec; 29(6):503-506. PubMed ID: 26456846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
